Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. STKE, 25 January 2005
Vol. 2005, Issue 268, p. pe2
[DOI: 10.1126/stke.2682005pe2]

PERSPECTIVES

Diabetes Outfoxed by GLP-1?

George G. Holz* and Oleg G. Chepurny

Department of Physiology and Neuroscience, New York University School of Medicine, New York, NY 10016, USA.

Abstract: Foxo1, a member of the Fox0 subfamily of winged-helix forkhead transcription factors, is a target of insulin and insulin-like growth factor–1 (IGF-1) signal transduction pathways that activate protein kinase B (PKB) in pancreatic β cells. Foxo1 is a substrate for PKB, and its phosphorylation results in nuclear exclusion with concomitant alterations in gene expression that are important to cellular growth and differentiation. Because activation of PKB can require insulin receptor substrate proteins (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase (PI3K), it is of interest to determine whether the activity of Foxo1 is also regulated by heterotrimeric G protein–coupled receptors (GPCRs) with IRS-1 or -2, PI3K, or PKB signaling potential. Indeed, studies of β cells have demonstrated that activation of a GPCR for the blood glucose–lowering hormone GLP-1 leads to major alterations of IRS-2, PI3K, and PKB activity. By promoting nuclear exclusion of Foxo1 in a PKB-mediated manner, GLP-1 may up-regulate the expression of a homeodomain transcription factor (PDX-1) that serves as a master regulator of β-cell growth and differentiation. This STKE Perspective summarizes signaling properties of GLP-1 that may explain its ability to increase β-cell mass, to increase pancreatic insulin secretory capacity, and to lower levels of blood glucose in type 2 diabetic subjects.

*Corresponding author. MSB 442, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. Telephone, 212-263-5434; fax, 212-689-9060; e-mail: holzg01{at}popmail.med.nyu.edu

Citation: G. G. Holz, O. G. Chepurny, Diabetes Outfoxed by GLP-1? Sci. STKE 2005, pe2 (2005).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Skp2 Is Required for Incretin Hormone-Mediated {beta}-Cell Proliferation.
S.-I. Tschen, S. Georgia, S. Dhawan, and A. Bhushan (2011)
Mol. Endocrinol. 25, 2134-2143
   Abstract »    Full Text »    PDF »
Regulation of pancreatic islet gene expression in mouse islets by pregnancy.
B. T. Layden, V. Durai, M. V. Newman, A. M. Marinelarena, C. W. Ahn, G. Feng, S. Lin, X. Zhang, D. B. Kaufman, N. Jafari, et al. (2010)
J. Endocrinol. 207, 265-279
   Abstract »    Full Text »    PDF »
Enhanced Rap1 Activation and Insulin Secretagogue Properties of an Acetoxymethyl Ester of an Epac-selective Cyclic AMP Analog in Rat INS-1 Cells: STUDIES WITH 8-pCPT-2'-O-Me-cAMP-AM.
O. G. Chepurny, C. A. Leech, G. G. Kelley, I. Dzhura, E. Dzhura, X. Li, M. J. Rindler, F. Schwede, H. G. Genieser, and G. G. Holz (2009)
J. Biol. Chem. 284, 10728-10736
   Abstract »    Full Text »    PDF »
FOXO1 Plays an Important Role in Enhanced Microvascular Cell Apoptosis and Microvascular Cell Loss in Type 1 and Type 2 Diabetic Rats.
Y. Behl, P. Krothapalli, T. Desta, S. Roy, and D. T. Graves (2009)
Diabetes 58, 917-925
   Abstract »    Full Text »    PDF »
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment.
W. Kim and J. M. Egan (2008)
Pharmacol. Rev. 60, 470-512
   Abstract »    Full Text »    PDF »
Exendin-4 Stimulation of Cyclin A2 in {beta}-Cell Proliferation.
W.-J. Song, W. E. Schreiber, E. Zhong, F.-F. Liu, B. D. Kornfeld, F. E. Wondisford, and M. A. Hussain (2008)
Diabetes 57, 2371-2381
   Abstract »    Full Text »    PDF »
Generation of Nicotinic Acid Adenine Dinucleotide Phosphate and Cyclic ADP-Ribose by Glucagon-Like Peptide-1 Evokes Ca2+ Signal That Is Essential for Insulin Secretion in Mouse Pancreatic Islets.
B.-J. Kim, K.-H. Park, C.-Y. Yim, S. Takasawa, H. Okamoto, M.-J. Im, and U.-H. Kim (2008)
Diabetes 57, 868-878
   Abstract »    Full Text »    PDF »
The emerging role of FOXO transcription factors in pancreatic {beta} cells.
D. A Glauser and W. Schlegel (2007)
J. Endocrinol. 193, 195-207
   Abstract »    Full Text »    PDF »
Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic {beta}-Cell Mass..
J. Buteau, M. L. Spatz, and D. Accili (2006)
Diabetes 55, 1190-1196
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882